Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma
Daria Zdżalik-Bielecka(International Institute of Molecular and Cell Biology), Karolina Dzwonek(Medical University of Warsaw)
Cited by 36
Related Papers
Epithelial–mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells
|Gastric Cancer|2014|70
GAS6-AXL signaling triggers actin remodeling and macropinocytosis that drive cancer cell invasion
|bioRxiv (Cold Spring Harbor Laboratory)|2020|1